First, treatment
1. Surgical treatment
(1)Indications and contraindications: Only 5% to 10% of children with gastroesophageal reflux require surgical treatment, so the indications for surgery should be carefully selected. The following situations are indications for anti-reflux surgery: ①Failure of medical treatment or recurrence soon after stopping medication; ②Gastroesophageal reflux caused by congenital diaphragmatic hernia; ③Severe reflux complications, such as esophagitis with bleeding, ulcers, stricture, etc.; ④Recurrent respiratory infections and asphyxia caused by reflux; ⑤Objective evidence of pathological reflux (such as dynamic pH monitoring); ⑥Alkaline gastroesophageal reflux.
Cases requiring cautious consideration for anti-reflux surgery include: ①Insufficient medical treatment: including posture therapy, dietary adjustment, and taking acid-suppressing agents after meals and before bedtime. If after at least 6 weeks of treatment, the reflux symptoms still persist, consider performing a radioactive isotope examination of gastric emptying. If there is a gastric emptying disorder, additional gastric motility drugs can be used. If symptoms cannot be controlled even after this, further consideration should be given to surgical treatment. For effective treatment of gastroesophageal reflux and its complications, it is best for pediatric gastroenterologists and pediatric surgeons to collaborate in formulating a comprehensive treatment plan. ②Gastroesophageal reflux in the neonatal period and in small infants: The vast majority of gastroesophageal reflux occurring during this period is physiological and gradually resolves and heals with age. A small number of pathological gastroesophageal reflux can also be effectively treated with medical treatment, so surgery should be chosen with great caution. ③Lack of objective evidence of reflux disease: Such as recurrent upper respiratory tract infections, asphyxia, which cannot be definitely attributed to reflux, should not be treated surgically without hesitation. Otherwise, it may expand the surgical indications and lead to adverse treatment outcomes.
(2) Surgical principles: Anti-reflux surgery is achieved through the anatomical reconstruction of the fundus and cardia, restoring its normal closing ability to prevent reflux, which means it can be normally swallowed and also can vomit when necessary. The basic principles of anti-reflux surgery are: ① Increase the resting pressure of the lower esophageal sphincter: generally restore to twice the level of the resting pressure of the stomach to maintain a positive pressure barrier between the esophagus and stomach, usually achieved by wrapping the fundus around the distal esophagus. Relevant data indicates that the degree of fundoplication is proportional to the increase in sphincter pressure, with the Nissen 360° fundoplication showing the most significant pressure increase after surgery. ② Maintain a sufficient length of the abdominal segment of the esophagus: The abdominal segment of the esophagus is in an intraperitoneal positive pressure environment. During the operation, the abdominal segment of the esophagus should be freed up by 1.5 to 2.0 cm to maintain the closing state of the cardia. Clinically, whether it is Nissen, Belsey, or Hill surgery, the average length of the abdominal segment of the esophagus can be increased by about 1 cm. ③ The reconstructed cardia should be able to relax during swallowing: Under physiological conditions, swallowing is facilitated by the vagus nerve, causing the lower esophageal sphincter and the fundus to relax for about 10 seconds, and then quickly recover the tension before swallowing. Attention should be paid to protect the neural supply of the cardia during the operation, prevent injury to the vagus nerve, otherwise it may lead to relaxation of the cardia and loss of tension.
(3) Common surgical methods:
①Nissen surgery: Also known as 360° fundoplication, it is a commonly used anti-reflux surgery in clinical practice. The typical Nissen surgery involves an incision below the left rib, but the clinical practice often uses a median upper abdominal incision. After entering the abdomen, the left triangular ligament is cut, the left lobe of the liver is pulled to the right, and the abdominal segment of the esophagus is exposed. The retroperitoneum in front of it is incised, the phrenoesophageal membrane is incised, and a sufficient length of the abdominal segment of the esophagus is freed up, wrapped around with gauze. Then, the fundus of the stomach is freed up, the upper part of the gastrohepatic ligament is incised on the lesser curvature side, the splenic ligament is incised on the greater curvature side, and the short gastric vessels are transected. The free fundus should reach a state without tension after folding and suturing. Pay attention to protect the vagus nerve during the free process. The posterior wall of the freed fundus is pulled to the right behind the esophageal orifice, where it meets the anterior wall of the displaced stomach in front of the lower end of the esophagus, completing the circumferential wrapping of the fundus around the esophagogastric junction. Then, the fundus is folded and sutured; the folded fundus should not be sutured too tightly, and the suturing part should pass through the surgeon's index finger. The left and right crura of the diaphragm are sutured behind the esophagus to narrow the diaphragmatic hiatus. After suturing is complete, the esophagus beside it can accommodate the surgeon's index finger through the hiatus.
In fact, after the improvement of many authors, the Nissen fundoplication has included a variety of different surgical methods, and the trend is to strive for a shorter fundoplication suture. DeMeester advocates a single-stitch fundoplication to reduce swallowing difficulties and gas bloat syndrome (GBS). Other improved methods include partial fundoplication with reduced fundoplication degrees (less than 360°).
In addition, Nissen surgery can be combined with other surgeries to treat some complex gastroesophageal reflux patients. For example, Collis-Nissen surgery can be used for patients with short esophagus; Thal-Nissen for peptic esophageal stricture; for achalasia, perform esophageal muscular layer incision at the same time as total fundoplication, and there are still controversies about the postoperative results and method evaluation of these surgeries.
In summary, Nissen surgery can have the following aspects: A. Increase the pressure of the lower esophageal sphincter to form an effective esophageal-gastric anti-reflux positive pressure barrier. B. Increase the length of the abdominal esophagus, fully maintain the closure state of the esophageal orifice. C. The folded stomach acts as a valve, allowing the esophageal contents to pass in one direction; D. Constrict the esophageal hiatus.
According to a large number of literature reports, the cure rate of Nissen surgery can reach 88%, and 90% to 96% of patients have symptoms relief after surgery. The dynamic pH monitoring of 13 and 9 cases of gastroesophageal reflux surgery by DeMeester and Goodill showed that the acidic reflux index was restored to the normal range.
Nissen surgery is generally performed through the abdominal approach. The following situations should consider thoracic surgery: A. Repeat surgery for failed anti-reflux surgery; B. Accompanied by short esophagus; C. Lesions in the chest need to be treated, such as esophageal ulcer or diaphragmatic hernia, etc.
Belsey Mark IV surgery: a 240° partial anterior gastrectomy, the advantages of which are: A. Freely mobilize the lower esophagus to restore the lower esophageal sphincter to a longer high-pressure zone; B. Adequate exposure through the left thoracic approach; C. Particularly suitable for patients with severe esophagitis, esophageal motility disorders, and recurrent gastroesophageal reflux. Its disadvantages are that the muscle fibers of the esophageal wall are thin, and there is a possibility of cutting and tearing after suture. In addition, whether the partial fundoplication can effectively prevent reflux is still controversial.
③Hill surgery: Transabdominal posterior gastric fixation (transabdominal posterior gastropexy), commonly used for repairing hiatal hernia. The surgical principle is: A. Restore the length of the abdominal esophagus; B. Increase the angle between the stomach and esophagus (His angle); C. Tighten the esophageal lower sphincter sling fibers to strengthen the function of the lower esophageal sphincter; D. Narrow the diaphragmatic hiatus.
(4) Evaluation of surgical efficacy: The evaluation of the efficacy of anti-reflux surgery can be referred to the following indicators: ① Complete elimination of gastroesophageal reflux symptoms and complications; ② Ability to belch and expel excess gas in the stomach; ③ Nausea can occur when necessary; ④ Objective examination of gastroesophageal reflux, such as 24-hour dynamic pH monitoring, esophageal-gastric motility examination, etc., restored or close to normal range.
2. General treatment
In the treatment of gastroesophageal reflux in children, especially neonates and infants, posture and dietary feeding are very important.
(1) Prone position with the head tilted forward: The optimal position for the child is prone with the head tilted forward by 30° (including sleep time). Meyers and Herbst have successively confirmed that this position has the advantage that the esophagus-gastric junction is located at the top, reducing contact with acidic substances. It is more conducive to gastric emptying and reducing reflux than the right lateral sleeping position or the upper body elevated position. Orenstein et al. have confirmed through observation that the commonly used position therapy (conventional >45° or sitting up) actually promotes the exacerbation of gastroesophageal reflux, and the number of reflux episodes in the Jolly chair sitting position is 4 times that of the prone position with the head tilted forward by 30°.
(2) High-protein, low-fat diet: Physiological gastroesophageal reflux during sleep is very rare, most occurring within 2 hours after meals. Therefore, feeding can be done with thick, sticky paste-like foods, with small portions and frequent meals, mainly high-protein, low-fat meals to improve symptoms or reduce the frequency of vomiting. It is not advisable to drink beverages after dinner to avoid reflux, and it is best to avoid using spicy seasonings and foods or drugs that affect the lower esophageal sphincter tone.
3. Drug treatment
In the past 10 years, there has been rapid development, mainly involving two categories of drugs: prokinetics and acid inhibitors. Their combined use is more effective for reflux esophagitis. There is a wealth of experience in the treatment of gastroesophageal reflux in adults and older children, but at present, it is only in the observation and trial study stage in the neonatal period, so caution should be exercised when applying it to the latter.
(1) Prokinetic drugs:
①Bethanechol (Carbamylmethylcholine): A parasympathomimetic drug that increases the lower esophageal sphincter tone, reduces gastroesophageal reflux, and also enhances the amplitude of esophageal contraction, with the effect of clearing acidic substances and promoting gastric emptying. The pediatric dose is 8.7mg/m2 of body surface area. The main side effects are abdominal cramps, diarrhea, frequent urination, and blurred vision, but the side effects are mild and transient. Asthma is a relative contraindication to the drug.
②Metoclopramide: A peripheral and central nervous system dopamine receptor antagonist that can promote the release of acetylcholine from postganglionic nerve endings, increase the amplitude of esophageal contraction and the tension of the lower esophageal sphincter, promote gastric emptying, and has no effect on gastric acid secretion. The pediatric dose is 0.1mg/kg per dose, 3-4 times a day. However, long-term use can cause serious side effects, with about 1/3 of children developing neurological and mental symptoms such as anxiety, restlessness, insomnia, and acute extrapyramidal symptoms, which often force discontinuation of the drug. Long-term use of the drug is not ideal in clinical practice.
③Domperidone (Domperidone, Metoclopramide): Its antiemetic and gastrointestinal motility effects are based on its antagonism of dopamine receptors, affecting gastrointestinal motility. Due to poor penetration of the blood-brain barrier, it has almost no inhibitory effect on dopamine receptors in the brain, so it can exclude mental and neurological side effects. This drug can restore the peristalsis and tension of the upper gastrointestinal tract, promote gastric emptying, increase the motility of the antrum and duodenum, coordinate the contraction of the pylorus, and can also enhance the peristalsis and tension of the lower esophageal sphincter. The pediatric dose is 0.3mg/kg per dose, 3-4 times a day. Side effects are rare, and only occasional mild transient abdominal cramps and observable increase in serum prolactin levels can be observed, which can return to normal after discontinuation of the drug. When taking this drug, attention should also be paid to the fact that the use of anticholinergic drugs may weaken the drug effect. In addition, due to the incomplete development of metabolism and blood-brain barrier function in children under 1 year of age, great care should be taken when administering drugs to infants.
④Cisapride: A new and effective esophageal and gastrointestinal motility drug. It can increase gastric emptying and lower esophageal sphincter pressure, part of whose action is similar to cholinergic mechanisms, including the release of acetylcholine from the interstitial ganglion, which has no effect on gastric acid secretion and does not increase esophageal peristalsis. Its action range is wide, and it can improve the motor function of the entire digestive tract. The pediatric dose is 0.3mg/kg, three times a day. For infants from 5 days to 11 months old, the dose can be 0.15-0.2mg/kg, three times a day. It is reported that after taking the drug for 3-7 days, the reflux can be significantly improved. If combined with bronchopulmonary lesions, after taking the drug, not only the reflux can disappear, but also the symptoms of the lungs can be improved or disappear within a few weeks. The drug has few side effects, and only a few children may experience transient abdominal rumbling and loose stools, which are due to increased gastrointestinal motility.
(2) Antacid drugs:
①Cimetidine (Cimetidine, Nizatidine): An H2 histamine receptor antagonist, this drug is effective in reducing gastric acid secretion. In recent years, Cucchiara reported that the use of this drug in combination with antacid therapy for gastroesophageal reflux disease is relatively effective. The pediatric dose is 20-40mg/kg per day. The side effects are few. Generally, serious adverse reactions have not been found. There may be mild elevation of blood creatinine or serum transaminase, which can return to normal after discontinuation of the drug. A few patients who have taken the drug for a long time may develop breast development in males, and sometimes headaches, constipation, and diarrhea, which generally do not affect treatment. Occasionally, drug fever and rash may occur, and patients with reduced gastric function should reduce the dose accordingly.
② Ranitidine: It acts quickly and is an effective histamine H2 receptor antagonist. Its action is stronger than that of cimetidine, and it can inhibit the induced gastric acid secretion, that is, reduce its secretion volume and also reduce the acidity and pepsin content. Although it has no effect on increasing the lower esophageal sphincter tension, it is effective in treating gastroesophageal reflux disease. The pediatric dose is 5-10mg/kg. Adverse reactions are rare, and there have been no serious adverse reaction reports in foreign applications for many years. A few children (7% to 8%) may experience fatigue, headache, dizziness, and rash. Children with renal insufficiency should reduce the dosage accordingly.
③ Omeprazole: It is a new type of gastric acid secretion inhibitor that replaces benzimidazole. Its characteristic is that it can inhibit H/K-ATPase and block the final common pathway of H secretion in gastric parietal cells. In vivo, the anti-secretory effect of omeprazole and cimetidine on histamine-induced gastric acid secretion was measured, and the former was 10 times stronger than the latter.
④ Famotidine: According to literature reports, famotidine is effective in treating stage I and II gastroesophageal reflux disease. Sekigochi reported that 82% of patients healed within 12 weeks of adult medication. Its application in pediatric cases is still under observation and is not yet widely used.
(3) Mucosal Coating Drugs: When there is ulceration or mucosal erosion in gastroesophageal reflux disease, this drug can cover the surface of the lesion to form a protective film, alleviate symptoms, and promote healing. Such drugs include sucralfate, alginate antacid Gaviscon, potassium bismuth citrate (colloidal bismuth subcitrate, CBS), and recently, in the Chinese market, double octahedral montmorillonite (Smecta) is also used to treat esophagitis, with very satisfactory efficacy. Double octahedral montmorillonite has strong covering ability for the mucosa of the digestive tract and repairs and improves the defensive function of the mucosal barrier against attacking factors through interaction with mucus glycoproteins.
II. Prognosis
Currently, there is no relevant content description.